)
)
)
)
Expand your visibility at the BIO Investment and Growth Summit with a Company Presentation.
As a company leader, you can share your latest R&D progress, business strategy, and investment needs to shape the future of innovation and make new connections.
Benefits include:
- A dedicated webpage on the event website, inclusion in event marketing, and social sharing assets
- A podium presentation with capture of audio and slides
- A designated tag in the BIO Partnering™ system
- Post-presentation feedback from a communications or investor relations professional
- An invitation-only breakfast with other presenters and investors
Company Presentation applications are subject to approval and payment of the presentation fee.
Presentation Tiers
Premier presentations
13 minutes at the podium and have three categories of pricing:
- Pre-clinical is for companies that have not started clinical trials.
- Standard is for companies with active clinical trials, but no products on the market.
- Commercial is for companies with at least one product on the market.
Presentation Fees
| Pre-Clinical | Standard | Commercial | |
| Premier | $1,500 | $2,200 | $2,600 |
| Premium | $3,000 | ||
| Innovation Stage | $5,000 | ||
Here's who presented at the BIO Investment & Growth Summit in 2026:
Loading
-
Company PresentationAIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. We take a unique pan-antigenic approach for our cancer v ...Company Presentation
- Oncology
-
Company PresentationAlphyn Biologics, Inc. is advancing breakthrough therapies for skin diseases using its patented drug platform for first-in-class Multi-Target Therapeutics®. The company's platform technology is an inn ...Company Presentation
- Dermatology
-
Company PresentationAzitra is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. Azitra's lead program, ATR-12, uses an engineered strain of S. epidermidis de ...Company Presentation
- Dermatology
-
Company PresentationConsano Bio is a clinical-stage biotechnology company advancing a novel therapeutic designed to address serious pain conditions where conventional therapies are limited or ineffective. Its lead invest ...Company Presentation
- Regenerative Medicine
Speakers -
Company PresentationDuo Oncology is an oncology company reimagining chemotherapy, a foundational treatment for metastatic cancer. Its lead program, DUO-207, consolidates multi-drug chemotherapy regimens into a single, po ...Company Presentation
- Oncology
-
Company PresentationBased in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-de ...Company Presentation
- Gene/Cell Therapy
-
Company PresentationGATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% se ...Company Presentation
- Tools/Drug Development Support Tech
-
Company PresentationHalia Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies that target inflammation at its source. Our pipeline is built on a deep understanding of genetic resili ...Company Presentation
- Inflammation
-
Company PresentationImmuneOnco is a Hong Kong-listed (Stock Code: HK.1541) clinical-stage biotechnology company dedicated to discovering and developing immunotherapies for the treatment of cancer and other diseases. Timd ...Company Presentation
- Oncology
-
Company PresentationImmunophotonics, Inc. is developing an innovative therapy to prevent cancer from coming back after local tumor destruction (ablation) therapy. Advancements in cancer treatment, such as precision medic ...Company Presentation
- Oncology
-
Company PresentationInterAct Therapeutics (IAT) is a preclinical company advancing its proprietary InterAct Print™ platform to deliver transformative gene therapies for metastatic cancers. Our lead candidate, IAT-S2, tar ...Company Presentation
- Oncology
-
Company PresentationJecho Laboratories is a clinical-stage company focusing in oncology across fusion proteins, ADCs, TCEs, and bsAbs.Company Presentation
- Oncology
-
Company PresentationKaliVir Immunotherapeutics is a clinical-stage biotechnology company at the forefront of developing next-generation oncolytic immunotherapies. By harnessing the unique advantages of the vaccinia platf ...Company Presentation
- Oncology
-
Company PresentationKYAN Technologies is a functional precision medicine platform company dedicated to revolutionizing cancer care through our platform Optim.AI. This powerful tool empowers oncologists by providing them ...Company Presentation
- Diagnostics
Speakers -
Company PresentationModel Medicines is an AI-native biotechnology company developing first-in-class small-molecule therapeutics by targeting conserved biological choke points that drive disease across multiple indication ...Company Presentation
- Infectious Diseases
Speakers -
Company PresentationNewron is a biopharmaceutical company, headquartered in Bresso near Milan, Italy, the Company has a strong track record of advancing neuroscience-based treatments from discovery to market. Newron’s le ...Company Presentation
- CNS/Neurological
-
Company PresentationOncolytics is developing pelareorep, the only dsRNA REO virus being developed as an immunotherapy treatment for various tumors, including KRAS mutant MSS mCRC and 2L anal cancer. Pelareorep has achiev ...Company Presentation
- Oncology
Speakers -
Company PresentationPerseo Pharma is a biopharmaceutical company pioneering innovative metabolic therapies. The company has raised USD 12 million from private investors, including a U.S. patient advocacy organization and ...Company Presentation
- Metabolic Diseases
Speakers -
Company PresentationRakuten Medical is a clinical and commercial-stage biotech advancing its Alluminox™ photoimmunotherapy platform, which combines a drug and device to treat cancers. Its lead asset, ASP-1929, an EGFR-ta ...Company Presentation
- Oncology
-
Company PresentationResolution Therapeutics is a clinical stage pioneer in Regenerative Macrophage Therapies (RMT) for Inflammatory and Fibrotic Diseases. CLINICAL PROGRAM / HIGH UNMET NEED - EMERALD/OPAL (P1/2) for End ...Company Presentation
- Gene/Cell Therapy
-
Company PresentationSebastian BioPharma is a preclinical oncology company developing tumor-targeted, multi-pathway therapeutics for colorectal cancer and other immunotherapy-resistant solid tumors. Our lead program uses ...Company Presentation
- Oncology
-
Company PresentationSoligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics bus ...Company Presentation
- Orphan/Rare Diseases
-
Company PresentationA clinical stage company developing a sustained-release drug delivery platform with broad applications. Our first product, ST-01, has successfully completed its Phase II trial and is moving towards a ...Company Presentation
- Multiple Therapeutics
-
Company PresentationTessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is to cure disease ...Company Presentation
- Multiple Therapeutics
-
Company PresentationXM Therapeutics is a Brown University spinoff developing tissue repair and regeneration therapies for chronic disorders where an impaired healing response leads to progressive fibrosis (scarring), inf ...Company Presentation
- Multiple Therapeutics
For questions about Company Presentations, please contact us at Present@bio.org.
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}